CliffBio
small molecule

MOXATAG

AMOXICILLIN

Loss of exclusivityMay 2027latest FDA-listed patent expiry
CompanyPragma →See this company's full patent-cliff portfolio

Drug detail

Brand nameMOXATAG
Active ingredientAMOXICILLIN
Strength775MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2008
Marketing statusDISCN

Listed patents

PatentExpiresType
8299052May 2027use U-1304
8778924December 2026substance, product
8357394December 2026product

More from Pragma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MOXATAG patent cliff — loss of exclusivity May 2027 | CliffBio